Frontier Biotechnologies Inc. (SHA:688221)

China · Delayed Price · Currency is CNY

21.10

-0.40 (-1.86%)

At close: Apr 29, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals		129.47M	114.25M	84.74M	40.50M	46.62M
Pharmaceuticals Growth		13.32%	34.82%	109.22%	-13.13%	123.50%
Total		129.47M	114.25M	84.74M	40.50M	46.62M
Total Growth		13.32%	34.82%	109.22%	-13.13%	123.50%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China		129.47M	114.25M	84.74M	40.50M	46.62M
China Growth		13.32%	34.82%	109.22%	-13.13%	123.50%
Total		129.47M	114.25M	84.74M	40.50M	46.62M
Total Growth		13.32%	34.82%	109.22%	-13.13%	123.50%

Source: S&P Global Market Intelligence.